A transcriptional enhancer is thought to play a major role in determining tissue-specific expression of the imraunoglobulin heavy chain (IgH) gene (1-3). However in three B-lyraphoid cell lines the Ig enhancer has been lost due to a spontaneous deletion, yet heavy chain synthesis persists at a high level (4-6). In the case of the enhancerless delta chain gene (5) we wanted to test whether the IgH enhancer is no longer necessary for maintenance of transcription or whether perhaps a new enhancer was created de_ novo by the deletion process. To this end we have cloned the relevant portion of the variant IgH gene and transfected it into myeloma and hybridoma cells. We find that the reintroduced gene segment is not expressed unless it is linked again to an enhancer. The results suggest that the IgH enhancer is necessary for the onset of transcription, presumably by organizing the gene into stable transcription complexes, but is dispensable at later stages once the transcription unit is activated.
INTRODUCTION
During B-cell differentiation the genes which encode immunoglobulins undergo several rearrangements. The active heavy chain gene is formed by joining Vy, D and J^ sequences to form a complete V^DJn variable region gene which is at first expressed together with the constant region Cu (7-12). The resulting immunoglobulins belong to the IgM class. In further development the same V^DJn can switch from the expression together with Cu to the expression with other constant region (Cpj) genes, in a process which is called class switching (9,13,14).
Using the fluorescence-activated Cell sorter we had selected murine hybridoma cell lines which had switched iri vitro from IgM to IgD production. These class switch variants had deleted the Cu region and one of them, designated 267.7 6, had lost the IgH enhancer in addition to Cu but nevertheless maintained a high level of IgD production (5) .
We were facing the apparent paradox that an endogenous heavy chain gene lacking an enhancer was expressed at a high level, yet cloned heavy chain genes require an enhancer for efficient expression when introduced into B-lymphocyte cells by transfection (2, 3) . In addition, the location of the IgH enhancer within the constant region and the strict cell type specificity suggested a function in IgH gene expression. Therefore, we considered it unlikely that the enhancer effect is a mere transfection artefact, as has been suggested by others (4) . He decided to test some possible explanations for the persisting expression of the IgH gene after deletion of the enhancer sequence. Gene amplification, the most frequent mechanism of mammalian cells to compensate for inefficient expression of a mutant gene, could be ruled out since the enhancerless heavy chain gene is present at about one copy per cell and the inactive IgH locus is deleted (5) . This latter fact also excludes the possibility that an enhancer present in the nonfunctional IgH locus could somehow complement the enhancerless gene. Several other possibilities, however, had to be considered:
1) The high level of Ig production does not correspond to a high level of mRNA, i.e. transcription of the enhancerless Ig gene is inefficient but is compensated by an increase in translation efficiency.
2) The particular cell line 267.7 6 has acquired the property to express any enhancerless IgH gene at a high level, perhaps due to the presence of a transactivating protein like Adenovirus Ela (15) (16) (17) .
3) A new enhancer-like sequence has been formed within the recombined Ig heavy chain gene upon juxtaposition of the deletion endpoints.
4) Only the combination of the cloned and reintroduced 6 gene in its own host cell would result in efficient expression e.g. due to the presence of a mutant transcription factor which would erroneously recognize the IgH deletion region as an enhancer. 5) Another, perhaps remote cellular enhancer substitutes for the deleted heavy chain enhancer. 6) There is a requirement for an enhancer to organize the Ig heavy chain gene into an active transcription unit but thereafter the enhancer becomes dispensable.
MATERIALS AND METHODS Cells
Hybridoma cells 267.7u, 267.7 6 (5) and myeloma cells X63-Ag8 (18), a gift from S.Y. Chung, were grown in Dulbecco's modified Eagle's medium, 10* fetal calf serum (FCS), penicillin (100U/ml) and streptomycin (100ug/ml). Transfection 0.33 ug of plasmid DNA was transfected together with DEAEDextran as described (1) into X63-Ag8 and 267.7 5 cells. Immunofluoreacence Thirty-six hours after transfection cells were fixed with methanol/acetone (70:30).
For nuclear T-antigen cells were stained with a hamster anti-T-antigen serum (3h, 37*) and a FITC conjugated rabbit anti-hamster serum (1h, 37*). The number of cells staining for T-antigen was determined by fluorescence microscopy. The total number of cells was counted for 0.4mm 
RESULTS

RNA analysis
First of all, we wanted to verify that the enhancer-deletion cell line 267.7 6 produces not only high levels of Ig protein but also a correspondingly high level of Ig m-RNA (possibility 1). To this end, the amount of IgH transcripts produced by the enhancercontaining parental cell line 267.7u and the enhancerless 267.7 6 class switch variant were compared. As shown in Fig. 1 , the 267.7 5 cell line contains at least 50% as much Ig heavy chain Second, we tested cell line 267.76 for the requirement of enhancer sequences to express introduced genes efficiently, (possibility 2). Three recombinant plasmids were tested, all containing the SV40 T-antigen gene with its own promoter as a test gene for expression. Recombinant p2 4B contained no enhancer, whereas pDept and p24BE+ contained the SV40 and IgH enhancer, respectively (1). 36 hrs after transfection 10-20% of the 267.76 cells stained for T-antigen, if the plasmid contained either the SV40 or the IgH enhancer. Without enhancer no T-antigen expression could be detected (Table 1 ). This shows that the 267.76 cells are able to recognize enhancer signals correctly and that a gene introduced into 267.76 by transfection requires an enhancer for efficient transcription. Searching for enhancer activities It seemed, however, still possible that a new enhancer was created by the deletion process, in a manner similar to some rearranged SV40 deletion mutants (23, 24) . The endogenous heavy chain gene, after isolation and reintroduction into myeloma cells, would then be efficiently expressed even in the absence of the "classical" igH enhancer (possibility 3). To test this, we prepared a genomic library of the 267.75 cell line in phage L47.1 (25) . From this library we isolated a 9.5 kb Bam HI fragment encompassing the VDJ and C 6 region of the expressed heavy chain gene. This fragment was subcloned into pBR 327 (p267,7D, Fig. 2) .
In order to distinguish between expression of the reintroduced cloned gene and the endogenous one, p267.7D had to be modified. He constructed plasmid p267.7H (Fig. 2) , where the critical deletion region including all upstream VDJ sequences was linked as a 3.4 kb Bam HI -Eco RI fragment to the Eco RI -Xho I Cu region of plasraid pSV-Vu1 (3).
As a control, recombinant pB1-8H (Fig. 2) , which is a modification of pSV-Vu1 (3), was also transfected. pB1-8M contains the VDJ gene segment of pSV-Vu1 including the IgH enhancer with the Cu constant region. As another control the IgH enhancer was placed upstream of the p267.7H gene to yield plasmid p267.7MEN (Fig. 2) . Transfection into X63-Ag8 cells (an IgG1-secreting myeloma line) results in efficient expression of the chimeric 7MEN) , and, as expected with the PB1-8M control (Table 2 ). However, we could not detect expression from the enhancerless gene on recombinant p 267.7M. The used inmunofluorescence assay would have allowed detection of the expression from the mutant IgH gene at levels as low as 5% as those observed with the wild-type constructs (not shown).
Testing the clone in its own producer cell
In order to address the fourth possibility, we had to introduce the enhancerless gene into its own cell line, 267.7 5, since it seemed possible that it could only be active in that particular cell line. The data (Table 2) show that the cloned enhancerless gene segment is not active unless it is linked to a new enhancer.
DISCUSSION
In our studies we have found that IgH gene transcription persists at a high level after spontaneous deletion of the IgH enhancer. The cloned gene segment harboring the deletion region is not expressed unless it is linked again to an enhancer when transfected into myeloma and hybridoma cells, thus excluding the possibility that a new enhancer was created by the deletion rearrangement. Recently the same conclusion was independently reached by Zaller and Eckhardt (26) . These authors have cloned an IgG gene which was highly transcribed in the absence of an enhancer. Using stable transformation assays they have also found that the cloned gene was only active after linkage to an enhancer when introduced into myeloma cells. Our results complement and extend those of Zaller and Eckhardt. We have reached our conclusions using different cells, a different gene, and a different transfection technigue (transient expression versus stable transformation). In addition we obtained the same result when the enhancerless gene segment is transfected into its own producer cell, thus ruling out the obvious possibility that this cell line is mutated to efficiently express an enhancerless gene.
These experiments do not exclude the possibility 5 that in 267. 7 6 cells a remote cellular enhancer substitutes for the deleted Ig heavy chain enhancer. Given the ability of enhancers to act over distances of many thousand basepairs (2 7) this point is difficult to investigate since such a putative enhancer could well be outside of the VDJ-C 6 gene segment that we have cloned and analysed. So far, however, no additional IgH enhancer-like seguences have been found in the extended IgH region which has been tested for enhancer activity (1) (2) (3) 28, 29) .
We consider the last possibility (6) particularly appealing, namely that the Ig enhancer is dispensable in B-cells. During B cell differentiation, induction of heavy chain gene transcription does not have to be reversible. Thus a high transcription rate of the IgH gene may persist even if the sequence which was originally responsible for the organization of the chromatin into stable transcription complexes is accidentally removed.
Based on studies of the transcriptional regulation of 5S RNA genes, Brown (30) proposed a model for how the activated transcription status of a gene could be propagated epigenetically throughout further cell proliferation. This model involves cooperative interaction of newly synthesized transcription factors with those that are still bound to either one of the sister chromatids in such a way that after mitosis complete active transcription complexes are regenerated in both daughter cells. Stable transcription complexes have also been described for ribosomal RNA genes (31) and for an U 2 RNA gene which is transcribed by RNA polymerase II (32) .
Maintenance of active transcription complexes might also explain, as an indirect enhancer effect, the aberrant expression of c-myc when translocated to an Ig heavy chain locus by a recorn-bination event that removes the enhancer, a situation found in many myelomas and B lymphomas. This does not imply that enhancers generally are dispensable after the onset of transcription since the situation must be different for inducible genes such as metallothionein or interferon (33) (34) (35) (36) .
From the data presented in this paper and from previous results the following model of Ig heavy chain transcription can be proposed: At a "pro-pre-B cell stage", the heavy chain enhancer becomes active, presumably by binding celltype-specific factors, and the unrearranged heavy chain constant region starts to produce sterile transcripts (37, 38) . The variable regions are also transcribed, though only transiently (39) . After V H to DJH joining the active heavy chain gene is organized into a stable transcription complex. Finally, the presence of the IgH enhancer becomes dispensable. The IgH enhancer apparently is not required to maintain transcriptional activity after Ig class switching, i.e. introduction of new Cn-genes into the transcription unit, as we have shown for the 267.7 cell line.
